The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes. 2016

E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
State Research Institute for Genetics and Selection of Industrial Microorganisms, Moscow, Russia, 117545.

The modified asparaginase Was79 was derived from the recombinant wild-type L-asparaginase of Wolinella succinogenes. The Was79 contains the amino acid substitutions V23Q and K24T responsible for the resistance to trypsinolysis and the N-terminal heparin-binding peptide KRKKKGKGLGKKR responsible for the binding to heparin and tumor K562 cells in vitro. When tested on a mouse model of Fischer lymphadenosis L5178Y, therapeutic efficacy of Was79 was significantly higher than that of reference enzymes at all single therapeutic doses used (125-8000 IU/kg). At Was79 single doses of 500-8000 IU/kg, the complete remission rate of 100 % was observed. The Was79 variant can be expressed intracellularly in E. coli as a less immunogenic formyl-methionine-free form at high per cell production levels.

UI MeSH Term Description Entries
D007940 Leukemia L5178 An experimental lymphocytic leukemia of mice. Lymphoma L5178,L5178, Leukemia,L5178, Lymphoma
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001215 Asparaginase A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1. Asparaginase II,Asparaginase medac,Asparagine Deaminase,Colaspase,Crasnitin,Elspar,Erwinase,Kidrolase,Leunase,Paronal,Deaminase, Asparagine,medac, Asparaginase
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D016968 Wolinella A genus of gram-negative, anaerobic, rod-shaped bacteria isolated from the bovine RUMEN, the human gingival sulcus, and dental PULPITIS infections. Wolinella succinogenes

Related Publications

E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
October 1996, European journal of biochemistry,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
August 1996, Archives of microbiology,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
January 2017, Scientific reports,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
January 1974, Applied microbiology,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
October 2001, Archives of microbiology,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
October 2007, Antonie van Leeuwenhoek,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
July 1985, Journal of molecular biology,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
May 1992, European journal of biochemistry,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
June 1993, European journal of biochemistry,
E P Sannikova, and N V Bulushova, and S E Cheperegin, and I I Gubaydullin, and G G Chestukhina, and V V Ryabichenko, and I A Zalunin, and E K Kotlova, and G E Konstantinova, and T S Kubasova, and A A Shtil, and V S Pokrovsky, and S V Yarotsky, and B D Efremov, and D G Kozlov
January 1986, The Biochemical journal,
Copied contents to your clipboard!